Pictor Announces Funding Round After Successful Launch In New Zealand And Usa Of Sars-Cov-2 Antibody Test
Pictor Announces Funding Round After Successful Launch In New Zealand And Usa Of Sars-Cov-2 Antibody Test
12/04/22, 11:04 PM
Location
aucklandIndustry
health diagnostics
therapeutics
biotechnology
health care
Pictor, a global leader in immunodiagnostics, today announced a funding round to help accelerate pipeline product development projects along with market development activities within Australia/New Zealand, the US and Europe for its Human Health and Animal Health portfolios.
Company Info
Location
auckland, auckland, new zealand
Additional Info
Pictor is an in vitro diagnostics company that offers a patented multiplexed platform for highly accurate and efficient testing of complex and infectious diseases for human and animal health. PictArray™ multiplexed technology makes it possible to test multiple disease markers in a single test simultaneously — with higher sensitivity, faster throughput, and reduced turn-around time. The company’s lead product, the PictArray™ SARS-CoV-2 IgG ELISA Kit, enables more informed clinical intervention to manage the threat of COVID-19. For more information, please visit http://pictordx.com, https://www.linkedin.com/company/pictorltd and @PictorLtd on Twitter or Facebook.